vs
Pulmonx Corp(LUNG)与RBB Bancorp(RBB)财务数据对比。点击上方公司名可切换其他公司
RBB Bancorp的季度营收约是Pulmonx Corp的1.6倍($32.3M vs $20.6M),RBB Bancorp净利率更高(31.5% vs -66.3%,领先97.8%),RBB Bancorp同比增速更快(12.6% vs -8.7%),过去两年RBB Bancorp的营收复合增速更高(7.0% vs -0.5%)
Pulmonx Corp是一家主营介入肺病学医疗解决方案的全球医疗科技企业,主打用于治疗慢性阻塞性肺疾病、肺气肿的微创支气管内瓣膜产品,业务覆盖北美、欧洲、亚太等市场,为重症肺病患者提供低创伤治疗选择。
RBB银行控股公司是总部位于美国的金融控股集团,旗下核心主体为皇家商业银行,主要服务亚裔社群、中小微企业、不动产投资者及零售客户,提供商业信贷、储蓄存款、财富管理等多元金融服务,业务覆盖美国沿海核心都会区。
LUNG vs RBB — 直观对比
营收规模更大
RBB
是对方的1.6倍
$20.6M
营收增速更快
RBB
高出21.2%
-8.7%
净利率更高
RBB
高出97.8%
-66.3%
两年增速更快
RBB
近两年复合增速
-0.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $20.6M | $32.3M |
| 净利润 | $-13.7M | $10.2M |
| 毛利率 | 77.9% | — |
| 营业利润率 | -40.9% | 39.5% |
| 净利率 | -66.3% | 31.5% |
| 营收同比 | -8.7% | 12.6% |
| 净利润同比 | 5.5% | 132.1% |
| 每股收益(稀释后) | $-0.33 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LUNG
RBB
| Q1 26 | $20.6M | — | ||
| Q4 25 | $22.6M | $32.3M | ||
| Q3 25 | $21.5M | $32.6M | ||
| Q2 25 | $23.9M | $35.8M | ||
| Q1 25 | $22.5M | $28.5M | ||
| Q4 24 | $23.8M | $28.7M | ||
| Q3 24 | $20.4M | $30.3M | ||
| Q2 24 | $20.8M | $27.5M |
净利润
LUNG
RBB
| Q1 26 | $-13.7M | — | ||
| Q4 25 | $-10.4M | $10.2M | ||
| Q3 25 | $-14.0M | $10.1M | ||
| Q2 25 | $-15.2M | $9.3M | ||
| Q1 25 | $-14.4M | $2.3M | ||
| Q4 24 | $-13.2M | $4.4M | ||
| Q3 24 | $-14.1M | $7.0M | ||
| Q2 24 | $-15.3M | $7.2M |
毛利率
LUNG
RBB
| Q1 26 | 77.9% | — | ||
| Q4 25 | 77.6% | — | ||
| Q3 25 | 74.7% | — | ||
| Q2 25 | 72.1% | — | ||
| Q1 25 | 72.5% | — | ||
| Q4 24 | 74.0% | — | ||
| Q3 24 | 73.7% | — | ||
| Q2 24 | 73.7% | — |
营业利润率
LUNG
RBB
| Q1 26 | -40.9% | — | ||
| Q4 25 | -43.8% | 39.5% | ||
| Q3 25 | -66.9% | 40.7% | ||
| Q2 25 | -62.0% | 36.1% | ||
| Q1 25 | -64.6% | 11.2% | ||
| Q4 24 | -56.5% | 17.6% | ||
| Q3 24 | -69.3% | 31.6% | ||
| Q2 24 | -75.2% | 35.6% |
净利率
LUNG
RBB
| Q1 26 | -66.3% | — | ||
| Q4 25 | -46.1% | 31.5% | ||
| Q3 25 | -64.9% | 31.2% | ||
| Q2 25 | -63.6% | 26.1% | ||
| Q1 25 | -64.1% | 8.0% | ||
| Q4 24 | -55.4% | 15.3% | ||
| Q3 24 | -69.4% | 23.1% | ||
| Q2 24 | -73.7% | 26.4% |
每股收益(稀释后)
LUNG
RBB
| Q1 26 | $-0.33 | — | ||
| Q4 25 | $-0.25 | $0.59 | ||
| Q3 25 | $-0.34 | $0.59 | ||
| Q2 25 | $-0.38 | $0.52 | ||
| Q1 25 | $-0.36 | $0.13 | ||
| Q4 24 | $-0.33 | $0.26 | ||
| Q3 24 | $-0.36 | $0.39 | ||
| Q2 24 | $-0.39 | $0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $61.6M | $212.3M |
| 总债务越低越好 | $37.3M | $119.9M |
| 股东权益账面价值 | $45.8M | $523.4M |
| 总资产 | $120.0M | $4.2B |
| 负债/权益比越低杠杆越低 | 0.82× | 0.23× |
8季度趋势,按日历期对齐
现金及短期投资
LUNG
RBB
| Q1 26 | $61.6M | — | ||
| Q4 25 | $69.8M | $212.3M | ||
| Q3 25 | $76.5M | $234.9M | ||
| Q2 25 | $75.5M | $191.9M | ||
| Q1 25 | $74.6M | $238.8M | ||
| Q4 24 | $70.9M | $257.7M | ||
| Q3 24 | $63.3M | $349.4M | ||
| Q2 24 | $63.5M | $252.8M |
总债务
LUNG
RBB
| Q1 26 | $37.3M | — | ||
| Q4 25 | $37.1M | $119.9M | ||
| Q3 25 | $37.1M | $119.8M | ||
| Q2 25 | $37.1M | $119.7M | ||
| Q1 25 | $37.2M | $119.6M | ||
| Q4 24 | $37.2M | $119.5M | ||
| Q3 24 | $37.2M | $119.4M | ||
| Q2 24 | $37.2M | $119.3M |
股东权益
LUNG
RBB
| Q1 26 | $45.8M | — | ||
| Q4 25 | $54.1M | $523.4M | ||
| Q3 25 | $60.0M | $514.3M | ||
| Q2 25 | $69.1M | $517.7M | ||
| Q1 25 | $77.7M | $510.3M | ||
| Q4 24 | $85.8M | $507.9M | ||
| Q3 24 | $93.9M | $509.7M | ||
| Q2 24 | $101.2M | $511.3M |
总资产
LUNG
RBB
| Q1 26 | $120.0M | — | ||
| Q4 25 | $129.3M | $4.2B | ||
| Q3 25 | $138.3M | $4.2B | ||
| Q2 25 | $147.2M | $4.1B | ||
| Q1 25 | $150.7M | $4.0B | ||
| Q4 24 | $162.8M | $4.0B | ||
| Q3 24 | $167.4M | $4.0B | ||
| Q2 24 | $172.6M | $3.9B |
负债/权益比
LUNG
RBB
| Q1 26 | 0.82× | — | ||
| Q4 25 | 0.69× | 0.23× | ||
| Q3 25 | 0.62× | 0.23× | ||
| Q2 25 | 0.54× | 0.23× | ||
| Q1 25 | 0.48× | 0.23× | ||
| Q4 24 | 0.43× | 0.24× | ||
| Q3 24 | 0.40× | 0.23× | ||
| Q2 24 | 0.37× | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $43.4M |
| 自由现金流经营现金流 - 资本支出 | — | $42.6M |
| 自由现金流率自由现金流/营收 | — | 131.8% |
| 资本支出强度资本支出/营收 | — | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | — | $73.5M |
8季度趋势,按日历期对齐
经营现金流
LUNG
RBB
| Q1 26 | — | — | ||
| Q4 25 | $-7.1M | $43.4M | ||
| Q3 25 | $-8.2M | $2.1M | ||
| Q2 25 | $-3.9M | $21.7M | ||
| Q1 25 | $-13.2M | $7.8M | ||
| Q4 24 | $-6.7M | $58.5M | ||
| Q3 24 | $-7.2M | $24.5M | ||
| Q2 24 | $-5.8M | $11.7M |
自由现金流
LUNG
RBB
| Q1 26 | — | — | ||
| Q4 25 | $-7.1M | $42.6M | ||
| Q3 25 | $-8.3M | $1.8M | ||
| Q2 25 | $-4.0M | $21.6M | ||
| Q1 25 | $-13.5M | $7.6M | ||
| Q4 24 | $-6.8M | $57.7M | ||
| Q3 24 | $-7.7M | $24.2M | ||
| Q2 24 | $-6.2M | $11.5M |
自由现金流率
LUNG
RBB
| Q1 26 | — | — | ||
| Q4 25 | -31.4% | 131.8% | ||
| Q3 25 | -38.4% | 5.4% | ||
| Q2 25 | -16.6% | 60.2% | ||
| Q1 25 | -60.0% | 26.7% | ||
| Q4 24 | -28.8% | 201.0% | ||
| Q3 24 | -37.6% | 80.0% | ||
| Q2 24 | -30.0% | 42.0% |
资本支出强度
LUNG
RBB
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 2.5% | ||
| Q3 25 | 0.4% | 1.1% | ||
| Q2 25 | 0.2% | 0.3% | ||
| Q1 25 | 1.3% | 0.6% | ||
| Q4 24 | 0.5% | 2.7% | ||
| Q3 24 | 2.0% | 0.8% | ||
| Q2 24 | 2.3% | 0.5% |
现金转化率
LUNG
RBB
| Q1 26 | — | — | ||
| Q4 25 | — | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 3.50× | ||
| Q2 24 | — | 1.61× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图